Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.01164Source: DataRank Database

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.89)OA: goldTopics (25)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Margarite D. Matossian ORCID,Deniz A. Uçar,Steven Elliott ORCID,Jacqueline La,Maryl Wright

Live enrichment

PubMed:32850332 PMC:PMC7416559 OpenAlex:https://openalex.org/W3047511733

NCI NIH HHS

Grant: R01 CA174785

NCI NIH HHS

Grant: R15 CA176496

NIGMS NIH HHS

Grant: U54 GM104940

NCI NIH HHS

Grant: R01 CA125806

National Institutes of Health

Grant: 1R15CA176496-01A1

Novel small molecule inhibitors of MEK5_ERK5 for the treatment of breast cancer

National Institutes of Health

Grant: 5R01CA174785-04

Kinase mediated suppression of metastasis in breast cancer

National Institutes of Health

Grant: 5R01CA125806-05

MEK5-Erk5 in breast cancer resistance

National Institutes of Health

FWCI

0.89

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fonc.2020.01164

publisherhttps://doi.org/10.3389/fonc.2020.01164

publisherhttps://www.frontiersin.org/article/10.3389/fonc.2020.01164/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32850332

repositoryhttps://doaj.org/article/200b22265dbe421ba0329786d0153f68

Fields of Study

Melanoma and MAPK PathwaysCell Adhesion Molecules ResearchProtein Kinase Regulation and GTPase Signaling0301 basic medicine03 medical and health sciences

Keywords

Triple-negative breast cancerBreast cancerExtracellular matrixCancer researchExtracellularMedicineCancerInternal medicineOncologyBiologyCell biologyMetastasisTriple Negative Breast Cancer (Tnbc)Erk5 KinaseCryogenic Scanning Electron Microscopy (Cryo-sem)Clustered Regularly Interspaced Short Palindromic Repeats (Crispr) KnockoutEpithelial–Mesenchymal–TransitionExtracelluar MatixNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

FAIR Checklist

Authors (25)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)